Grants and Contributions

To support the development and implementation of oceans conservation and management activities in Canada.

Contribution as part of the Participant Funding Program to Constance Lake First Nation to assist in preparing for and engaging in Indigenous consultation activities and public participation opportunities associated with the assessment process for the Regional Assessment in the Ring of Fire Area.

Contribution as part of the Participant Funding Program to Marten Falls First Nation to assist in preparing for and engaging in Indigenous consultation activities and public participation opportunities associated with the assessment process for the Regional Assessment in the Ring of Fire Area.

Not a Project (Mandated or Core Funding)

OCAD U CO offers IRAP clients an eight-week participatory research workshop to learn how to foster empathy with customers, uncover customer needs, and develop impactful value propositions that align with customer motivations and behaviours. These services support IRAP’s mission to increase innovative capacity within clients and to offer innovation services to SMEs in Canada.

The recipient proposes to optimize and perform a proof of concept study that combines microfluidic and molecular assay that detect SARS-CoV-2 from saliva by a color change in 30 minutes with minimum sensitivity of 10-18 mol. The microfluidic system will contain compartments with different steps of the assay. This assay consists of reagents that aim to amplify the SARS-CoV-2 genetic material (e.g. E gene) by 10 thousand fold. The amplified genetic material should bind to 13-nm gold nanoparticles coated with complementary single stranded DNA. The color of the solution should change because the gold nanoparticle will be assembled onto the SARS-CoV-2 amplified gene. The clustering of the gold nanoparticle changes how the electrons move leading to different absorbance properties. This physical process can be visualized by the change in the solution color from red to blue of the gold nanoparticles. A positive detection occurs when the solution is blue. The team propose to develop a microfluidic chip where different chambers to control each of the diagnostic assay reactions. The team will load diagnostic formulations (consist of enzymes, salts, and gold nanoparticle-conjugates) in each chamber. Individual reactions will occur by flowing the liquid from one chamber to the next in a consumable device that can be actuated with the use of an instrument in the simplest implementation.

The UKRI will hold a call for proposals aiming to solicit collaborations between UK researchers and the National Research Council of Canada’s Cell and Gene Therapy (CGT) Challenge Program, on research projects aiming to innovate therapeutic viral vector biomanufacturing processes. The UKRI will enter into funding agreements with successful research organizations (academic, not-for- profit, and/or small- and medium-sized enterprises (SMEs)) selected via competitive peer review process.
The aim of the call for proposals is to support improvements in biomanufacturing for cost-effective gene and cell-based therapies through one of two of the following collaborative areas:
1) Process improvement for adeno-associated virus (AAV) based gene therapy.
2) Deployment of process analytical technologies to perfusion-enabled lentiviral vector manufacturing.

Support provided to INGSA to support the International Conference on Science Advice to Governments (INGSA2021), a hybrid event (virtual and in-person) which aims to promote scientic advice to governments. It will bring together more than 1500 delegates from government, politics and diplomacy, the public and private sectors as well as academia.

The UKRI will hold a call for proposals aiming to solicit collaborations between UK researchers and the National Research Council of Canada’s Cell and Gene Therapy (CGT) Challenge Program, on research projects aiming to innovate therapeutic viral vector biomanufacturing processes. The UKRI will enter into funding agreements with successful research organizations (academic, not-for- profit, and/or small- and medium-sized enterprises (SMEs)) selected via competitive peer review process.
The aim of the call for proposals is to support improvements in biomanufacturing for cost-effective gene and cell-based therapies through one of two of the following collaborative areas:
1) Process improvement for adeno-associated virus (AAV) based gene therapy.
2) Deployment of process analytical technologies to perfusion-enabled lentiviral vector manufacturing.

Celebration and Commemoration Program